NL-OMON49947
Recruiting
Not Applicable
Platelet-activation and optimal inhibition in patients with Atrial Fibrillation undergoing LAA closure; The POPULAR-LAAO trial - POPULAR-LAAO
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Afib
- Sponsor
- Sint Antonius Ziekenhuis
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- The subject is aged 18 years or older
- •\- The subject is accepted/scheduled for left atrial appendage closure
- •\- The subject has a CHA\*DS\*\-VASc Score \>\=2 (male) or \>\=3 (female)
- •\- The subject or legal representative is able to understand and is willing to
- •provide written informed consent to participate in the trial.
Exclusion Criteria
- •\- Unable or unwilling to return for required follow\-up visits and examinations
- •\- Mechanical heart valves or valvular disease requiring surgery or
- •interventional procedure
- •\- Ongoing major bleeding or complicated or recent (\<72hours) major surgery
- •\- Known large oesophageal varices or decompensated liver disease (unless a
- •documented positive opinion of a gastro\-enterologist)
- •\- Severe thrombocytopenia (\<50,000/ml)
- •\- High likelihood of being unavailable for follow\-up or psycho\-social condition
- •making study participation impractical.
- •\- Woman with child bearing potential who do not use an efficient method of
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
ASsesment of Platelet function and Inhibition in patients Recovering from severe INfectionAcute myocardial infarctionHeart attack10011082NL-OMON50157Vrije Universiteit Medisch Centrum97
Active, not recruiting
Phase 1
Evaluation of platelet activity in patients recovering from a severe infectioHyperaggregability of thrombocytes triggered by severe infection (i.e. pneumonia or invasive urinary tract infection or a cutaneous infection).Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2016-004303-32-NLVU university medical center62
Not yet recruiting
Phase 4
The magnitude of platelet inhibition and the pharmacokinetics of a 600 mg loading dose of clopidogrel, in different patient categories (stable angina versus acute-coronary syndromes versus ST-elevated myocardial infarction).patients with a history of a stent thrombosis1003553410011082NL-OMON33697Cardiology200
Completed
Not Applicable
Inhibitory efficacy in platelet aggregation and pharmacokinetics of single oral administration of 300mg clopidogrel and 20mg prasugrelIschemic heart diseases with PICJPRN-UMIN000014161Kazuo Umemura Center for clinical research Hamamatsu University Hospital50
Completed
Phase 4
The effects of aspirin and ticagrelor on infection-mediated platelet activation in healthy volunteers.Acute coronary syndromeCardiovascular - Coronary heart diseaseBlood - Normal development and function of platelets and erythrocytesACTRN12616001508460Kathryn Hally10